Form 4: Mirum Pharmaceuticals Executive Acquires Shares Through Employee Stock Purchase Plan

Joanne Quan, Chief Medical Officer of Mirum Pharmaceuticals, acquired 118 shares of common stock through the company's Employee Stock Purchase Plan.

Summary

• Joanne Quan, the Chief Medical Officer of Mirum Pharmaceuticals, acquired 118 shares of the company's common stock.
• The shares were acquired on November 8, 2024, through the company's Employee Stock Purchase Plan.
• The price per share was $21.046.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, which is generally neutral to positive. The acquisition of shares by an executive can be seen as a sign of confidence in the company.

Positives

• The acquisition of shares by a company executive can be seen as a positive sign of confidence in the company's future.

Industry Context

This type of transaction is common for employees of publicly traded companies, especially those participating in employee stock purchase plans. It reflects a standard practice for aligning employee interests with company performance.

Comparison to Industry Standards

• Employee stock purchase plans are a common benefit offered by many publicly traded companies, including those in the pharmaceutical industry.
• The share acquisition by Joanne Quan is similar to transactions seen at other companies where executives participate in such plans.
• The price of $21.046 per share is specific to Mirum Pharmaceuticals and would need to be compared to the company's historical trading data and peer group valuations to assess its significance.

Stakeholder Impact

• The share acquisition has a minor positive impact on shareholders as it indicates confidence from a company executive.

Key Dates

Keywords

Mirum Pharmaceuticals, Employee Stock Purchase Plan, insider trading, share acquisition, common stock, Joanne Quan, MIRM